About Us

CapsoVision is a commercial-stage medical technology company that develops advanced imaging and artificial intelligence (“AI”) technologies, deployed in its capsule endoscopy solutions to identify abnormalities of the gastrointestinal (“GI”) tract for diagnostic and screening purposes. The Company developed its first capsule endoscope system, currently comprising the CapsoCam Plus single-use capsule and CapsoCloud and CapsoView software, to panoramically visualize the small-bowel mucosa to detect abnormalities such as obscure GI bleeding and Crohn’s disease. The capsule acquires and stores video images in onboard memory while moving through the GI tract, and the software component allows healthcare providers to view the video retrieved from the capsule—either by streaming it from the cloud, where it is securely stored, to anywhere, at their convenience, using CapsoCloud software, or downloading it from the capsule themselves and reviewing it in CapsoView software. The CapsoCam is a wire-free capsule endoscopy solution, eliminating patient-worn data recorders and providing clinicians a zero-capex, maintenance free, flexible, and scalable workflow. The CapsoCam Plus is classified as a Class II device and has received FDA marketing authorization through the 510(k) clearance process. 

 

Our product development philosophy is driven by our mission to continuously empower clinicians and patients. Through our innovations in the field of diagnostic imaging, we aim to provide products that streamline clinical operations while allowing for better diagnostic outcomes and improved patient quality of life.